Pricing and Access Strategies
High drug costs remain a barrier in the Eylea Market, particularly in developing countries. In wealthier markets, insurance coverage offsets patient costs, but in low-income regions, affordability is a challenge. To address this, companies are using tiered pricing, government partnerships, and patient assistance programs. Inclusion of Eylea in public health insurance schemes is a critical factor for expanding adoption in Asia, Latin America, and Africa. Sustainable pricing models will be key for long-term growth.
5 Ansichten
